Stay updated on Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.

Latest updates to the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page
- Check4 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded the disease keyword Gastric cancer and updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check40 days agoChange DetectedFooter revision label updated from v3.4.0 to v3.4.1; no changes to study data or page navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedUI/text updates include a glossary toggle, updated QC-related labels, and new footer/version information (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0), with no changes to the core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 updated from v3.3.3. This appears to be a metadata update and does not affect the study information displayed on the page.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a Locations section listing study sites across Alabama, Arizona, California, Florida, Michigan, New Jersey, New York, North Carolina, Oregon, Pennsylvania, and Tennessee, and updated the page to Revision: v3.3.3.SummaryDifference0.9%

Stay in the know with updates to Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of INCAGN01949 With Immune Therapies Clinical Trial page.